Comac Medical

Executive Summary

Comac Medical is a Pan-European full-service Contract Research Organization (CRO) founded in 2013, specializing in clinical trials from Phase I to IV, medical devices, and food supplements. Headquartered in Sofia, Bulgaria, the company has built deep regional expertise across Europe and Eurasia, leveraging a flexible, client-centric partnership model to deliver tailored clinical solutions. With a team of 201-500 employees, Comac Medical positions itself as a leading CRO in Eastern Europe, offering comprehensive services that range from trial design to regulatory support. The company has demonstrated its capabilities through several completed trials, including influenza vaccines and treatments for diabetic neuropathic foot ulcers, as well as an ongoing study for hepatic impairment. As a private entity, Comac Medical continues to grow its footprint by attracting new sponsors and expanding its therapeutic areas. The CRO market is expected to benefit from increased pharmaceutical R&D outsourcing, particularly in Europe, which could drive further growth for Comac Medical. However, the lack of recent public catalysts or funding rounds suggests a steady but unexceptional trajectory.

Upcoming Catalysts (preview)

• TBDPotential data readout from GB1211 hepatic impairment trial40% success